By ALICIA MUNDY And BRENT KENDALL WASHINGTON—A longtime chemist at the Food and Drug Administration was charged Tuesday with insider trading by federal authorities, who alleged he made as much as $3.6 million trading drug company stocks based on confidential drug-approval information. The Securities and Exchange Commission filed civil charges against Cheng Yi Liang, 57, […]